Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J SMALL

Showing results (781-790 of 1,203) with videos related to

Pageof 121
Sort By:
Gastrointestinal Endoscopy|February 2, 2016
Natural history and management of refractory benign esophageal stricturesAlessandro Repici, Aaron J Small, Aaron Mendelson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 27, 2007
Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 studyAnthony V D'Amico, Susan Halabi, Clare Tempany, et al.
Neuroendocrinology|November 29, 2002
The hypothalamic mechanisms of the hypophysiotropic action of ghrelinAlison M Wren, Caroline J Small, Charlotte V Fribbens, et al.
Psycho-Oncology|March 16, 2012
Factors associated with breast cancer worry 3 years after completion of adjuvant treatmentKristin M Phillips, Heather L McGinty, Brian D Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group BD M Savarese, S Halabi, V Hars, et al.
Cellular Microbiology|July 20, 2006
Cryptosporidium parvum infects human cholangiocytes via sphingolipid-enriched membrane microdomainsJeremy B Nelson, Steven P O'Hara, Aaron J Small, et al.
ACS Applied Materials & Interfaces|October 8, 2025
Exceptional NH<sub>3</sub> Detection by Cu(cyhdc) MOF Sensor Due to H<sub>2</sub>O CoadsorptionLeo J Small, Stephen J Percival, Matthew J Hurlock, et al.
BJU International|February 1, 2008
A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancerCharles J Ryan, Andrea H Harzstark, Jonathan Rosenberg, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|June 9, 2020
Accommodation of Anxiety in Youth with Autism Spectrum Disorder: Results from the TAASD StudyHannah E Frank, Elana R Kagan, Eric A Storch, et al.
Clinical Genitourinary Cancer|July 25, 2007
A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancerAmy M Lin, Brian I Rini, Mika K Derynck, et al.
Pageof 121

Showing results (781-790 of 1,203) with videos related to

Sort By:
Pageof 121
Gastrointestinal Endoscopy|February 2, 2016
Natural history and management of refractory benign esophageal stricturesAlessandro Repici, Aaron J Small, Aaron Mendelson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 27, 2007
Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 studyAnthony V D'Amico, Susan Halabi, Clare Tempany, et al.
Neuroendocrinology|November 29, 2002
The hypothalamic mechanisms of the hypophysiotropic action of ghrelinAlison M Wren, Caroline J Small, Charlotte V Fribbens, et al.
Psycho-Oncology|March 16, 2012
Factors associated with breast cancer worry 3 years after completion of adjuvant treatmentKristin M Phillips, Heather L McGinty, Brian D Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group BD M Savarese, S Halabi, V Hars, et al.
Cellular Microbiology|July 20, 2006
Cryptosporidium parvum infects human cholangiocytes via sphingolipid-enriched membrane microdomainsJeremy B Nelson, Steven P O'Hara, Aaron J Small, et al.
ACS Applied Materials & Interfaces|October 8, 2025
Exceptional NH<sub>3</sub> Detection by Cu(cyhdc) MOF Sensor Due to H<sub>2</sub>O CoadsorptionLeo J Small, Stephen J Percival, Matthew J Hurlock, et al.
BJU International|February 1, 2008
A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancerCharles J Ryan, Andrea H Harzstark, Jonathan Rosenberg, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|June 9, 2020
Accommodation of Anxiety in Youth with Autism Spectrum Disorder: Results from the TAASD StudyHannah E Frank, Elana R Kagan, Eric A Storch, et al.
Clinical Genitourinary Cancer|July 25, 2007
A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancerAmy M Lin, Brian I Rini, Mika K Derynck, et al.
Pageof 121